300725 药石科技
开盘竞价 07-24 09:30:00
资讯
新帖
简况
药石科技:截至2025年7月10日股东人数为34,001名
证券之星 · 20分钟前
药石科技:截至2025年7月10日股东人数为34,001名
【机构调研记录】融通基金调研药石科技
证券之星 · 07-11
【机构调研记录】融通基金调研药石科技
药石科技最新公告:员工持股平台拟减持不超2.72%公司股份
证券之星 · 07-10
药石科技最新公告:员工持股平台拟减持不超2.72%公司股份
药石科技:长江证券、宁银理财等多家机构于7月9日调研我司
证券之星 · 07-10
药石科技:长江证券、宁银理财等多家机构于7月9日调研我司
药石科技最新公告:董事陈谌拟减持不超过1.3万股股份
证券之星 · 07-03
药石科技最新公告:董事陈谌拟减持不超过1.3万股股份
药石科技:构建ADC药物领域全流程服务体系
证券之星 · 07-02
药石科技:构建ADC药物领域全流程服务体系
6月30日药石科技涨5.48%,东方量化成长灵活配置混合A基金重仓该股
证券之星 · 06-30
6月30日药石科技涨5.48%,东方量化成长灵活配置混合A基金重仓该股
药石科技涨5.98%,开源证券一个月前给出“买入”评级
证券之星 · 06-27
药石科技涨5.98%,开源证券一个月前给出“买入”评级
CRO概念盘中拉升,药石科技涨7.74%
市场透视 · 06-27
CRO概念盘中拉升,药石科技涨7.74%
药石科技(300725.SZ)参股公司药捷安康在香港联交所主板挂牌上市
智通财经 · 06-23
药石科技(300725.SZ)参股公司药捷安康在香港联交所主板挂牌上市
药石科技收盘下跌2.62%,滚动市盈率32.83倍,总市值67.59亿元
金融界 · 06-19
药石科技收盘下跌2.62%,滚动市盈率32.83倍,总市值67.59亿元
药石科技:截至2025年6月10日,公司股东人数为
证券之星 · 06-13
药石科技:截至2025年6月10日,公司股东人数为
药石科技:公司董事会将在授权期限内灵活安排融资事宜
证券之星 · 05-28
药石科技:公司董事会将在授权期限内灵活安排融资事宜
药石科技:年产155吨创新药及关键中间体CDMO建设项目建设周期为2023年7月至2026年7月
证券之星 · 05-26
药石科技:年产155吨创新药及关键中间体CDMO建设项目建设周期为2023年7月至2026年7月
每周股票复盘:药石科技(300725)股东吴希罕减持74.38万股
证券之星 · 05-23
每周股票复盘:药石科技(300725)股东吴希罕减持74.38万股
药石科技收盘下跌1.72%,滚动市盈率31.68倍,总市值65.21亿元
金融界 · 05-22
药石科技收盘下跌1.72%,滚动市盈率31.68倍,总市值65.21亿元
5月21日药石科技发布公告,股东减持74.38万股
证券之星 · 05-21
5月21日药石科技发布公告,股东减持74.38万股
药石科技:公司提供的产品和服务主要视合作伙伴的项目需求而定
证券之星 · 05-21
药石科技:公司提供的产品和服务主要视合作伙伴的项目需求而定
药石科技:为全球医药研发制造领域提供创新化学产品和服务
金融界 · 05-21
药石科技:为全球医药研发制造领域提供创新化学产品和服务
药石科技(300725)4月18日股东户数3.35万户,较上期减少0.57%
证券之星 · 05-09
药石科技(300725)4月18日股东户数3.35万户,较上期减少0.57%
加载更多
公司概况
公司名称:
南京药石科技股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2017-11-10
主营业务:
南京药石科技股份有限公司的主营业务是药物分子砌块的研发、工艺开发、生产和销售;基于药物分子砌块的药物发现解决方案;基于药物分子砌块的药物开发和生产服务(CDMO)。公司的主要产品是药物研究阶段的产品和服务、化学研发服务、药物开发及商业化阶段的产品和服务。公司凭借连续流创新工艺(连续脱羧、脱色、萃取和分离)、微填充床技术应用(连续空气氧化和加氢还原胺化)两项突破性技术,在与全球知名CDMO公司的激烈角逐中,连续两年(2023 年、2024 年)荣获美国化学学会(ACS)CMO 绿色化学卓越奖。
发行价格:
11.32
{"stockData":{"symbol":"300725","market":"SZ","secType":"STK","nameCN":"药石科技","latestPrice":41.2,"timestamp":1753320189000,"preClose":41.31,"halted":0,"volume":0,"delay":0,"changeRate":-0.0027,"floatShares":169000000,"shares":200000000,"eps":1.0307,"marketStatus":"开盘竞价","change":-0.11,"latestTime":"07-24 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":41.2,"askSize":126,"bidPrice":41.2,"bidSize":126,"shortable":0,"etf":0,"ttmEps":1.0307,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753320600000},"marketStatusCode":1,"adr":0,"adjPreClose":41.31,"symbolType":"stock","openAndCloseTimeList":[[1753320600000,1753327800000],[1753333200000,1753340400000]],"highLimit":45.44,"lowLimit":37.18,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":199730378,"isCdr":false,"pbRate":2.85,"roa":"--","peRate":39.972834,"roe":"1.19%","epsLYR":1.1,"committee":-0.329787,"marketValue":8229000000,"turnoverRate":0,"status":1,"floatMarketCap":6948000000},"requestUrl":"/m/hq/s/300725","defaultTab":"news","newsList":[{"id":"2553216282","title":"药石科技:截至2025年7月10日股东人数为34,001名","url":"https://stock-news.laohu8.com/highlight/detail?id=2553216282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553216282?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:03","pubTimestamp":1753319002,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技(300725)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问:截至到2025年7月10日贵公司的股东人数是多少?药石科技回复:投资者您好,截至2025年7月10日,公司股东人数为:34,001名。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072400005875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"gpt_icon":0},{"id":"2550727536","title":"【机构调研记录】融通基金调研药石科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2550727536","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550727536?lang=zh_cn&edition=full","pubTime":"2025-07-11 08:03","pubTimestamp":1752192225,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息及7月10日披露的机构调研信息,融通基金近期对1家上市公司进行了调研,相关名单如下:1)药石科技 调研纪要:药石科技在CDMO业务方面,产能利用率稳定在60%-70%,新车间产能利用率处于爬升期,新签订单延续增长趋势。融通基金成立于2001年,截至目前,资产管理规模1507.19亿元,排名44/210;资产管理规模743.37亿元,排名56/210;管理公募基金数172只,排名41/210;旗下公募基金经理39人,排名30/210。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100005126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"gpt_icon":0},{"id":"2550623546","title":"药石科技最新公告:员工持股平台拟减持不超2.72%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2550623546","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550623546?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:00","pubTimestamp":1752152427,"startTime":"0","endTime":"0","summary":"药石科技(300725.SZ)公告称,公司员工持股平台南京诺维科思创业投资合伙企业(有限合伙)计划在公告披露之日起十五个交易日后的三个月内,以集中竞价、大宗交易方式减持其持有的全部公司股份,不超过540.47万股,占剔除已回购股份后总股本的2.7174%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000036473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"gpt_icon":0},{"id":"2550644956","title":"药石科技:长江证券、宁银理财等多家机构于7月9日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2550644956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550644956?lang=zh_cn&edition=full","pubTime":"2025-07-10 19:03","pubTimestamp":1752145404,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年7月10日药石科技发布公告称长江证券、宁银理财、北大方正人寿资管、申万菱信基金、永赢基金、国海富兰克林基金、宝盈基金、融通基金、东方红资管、易方达基金、交银施罗德基金于2025年7月9日调研我司。药石科技2025年一季报显示,公司主营收入4.55亿元,同比上升20.55%;归母净利润3579.08万元,同比下降27.67%;扣非净利润3053.71万元,同比下降26.29%;负债率38.47%,投资收益435.66万元,财务费用1072.46万元,毛利率30.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000031616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0183","000783","BK0276","BK0201","BK0229","BK0188"],"gpt_icon":0},{"id":"2548809583","title":"药石科技最新公告:董事陈谌拟减持不超过1.3万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2548809583","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548809583?lang=zh_cn&edition=full","pubTime":"2025-07-03 19:29","pubTimestamp":1751542177,"startTime":"0","endTime":"0","summary":"药石科技(300725.SZ)公告称,公司董事陈谌持有公司股份5.46万股,计划在本减持计划预披露公告之日起十五个交易日后的三个月内,以集中竞价方式减持公司股份不超过1.3万股,占剔除已回购股份后总股本的0.0065%。减持原因为家庭资金需求,减持股份来源为2019年限制性股票股权激励股份以及实施权益分派送转的股份。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070300032999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"gpt_icon":0},{"id":"2548786907","title":"药石科技:构建ADC药物领域全流程服务体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2548786907","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548786907?lang=zh_cn&edition=full","pubTime":"2025-07-02 16:33","pubTimestamp":1751445197,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技07月02日在投资者关系平台上答复投资者关心的问题。在ADC药物领域,公司充分发挥分子砌块技术优势与一体化CMC平台能力,聚焦早期研发赋能与差异化技术突破,构建覆盖Linker-Payload合成、毒素修饰、大分子偶联工艺开发及GMP生产的全流程服务体系。依托已建成的高活性原料药生产线,公司持续扩充专业技术团队,满足下游日益增长的ADC项目需求,详细进展请关注公司定期报告,请注意投资风险,谨慎投资,谢谢!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070200026178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"gpt_icon":0},{"id":"2547065851","title":"6月30日药石科技涨5.48%,东方量化成长灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2547065851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547065851?lang=zh_cn&edition=full","pubTime":"2025-06-30 16:28","pubTimestamp":1751272086,"startTime":"0","endTime":"0","summary":"证券之星消息,6月30日药石科技涨5.48%创60日新高,收盘报38.7元,换手率8.87%,成交量14.94万手,成交额5.6亿元。重仓药石科技的公募基金请见下表:该股最近90天内共有5家机构给出评级,买入评级5家;过去90天内机构目标均价为36.66。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为东方基金的东方量化成长灵活配置混合A。该公募基金现任基金经理为王怀勋。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025063000021070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"gpt_icon":0},{"id":"2546790851","title":"药石科技涨5.98%,开源证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2546790851","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546790851?lang=zh_cn&edition=full","pubTime":"2025-06-27 16:28","pubTimestamp":1751012924,"startTime":"0","endTime":"0","summary":"今日药石科技(300725)涨5.98%,收盘报36.69元。2025年4月29日,开源证券研究员余汝意,聂媛媛发布了对药石科技的研报《公司信息更新报告:2025Q1营收增速稳健,海外市场贡献业绩核心弹性》,该研报对药石科技给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为72.88%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为西部证券的徐子悦。药石科技(300725)个股概况:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700026692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","300725"],"gpt_icon":0},{"id":"2546612487","title":"CRO概念盘中拉升,药石科技涨7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546612487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546612487?lang=zh_cn&edition=full","pubTime":"2025-06-27 10:21","pubTimestamp":1750990874,"startTime":"0","endTime":"0","summary":"06月27日,CRO概念盘中拉升,截至10点21分,CRO概念整体指数上涨2.04%,报453.890点。从个股上来看,该概念的成分股中,药石科技涨7.74%,成都先导涨幅超过5%。从资金上来看,截止发稿,CRO概念主力净流入为2.08亿,其中康龙化成受到资金热捧,主力净流入6685.52万;拉长时间线来看,该板块近20日主力资金净流入-48.20亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627102114a71fce16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627102114a71fce16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688222","BK0216","BK0229","300725"],"gpt_icon":0},{"id":"2545419002","title":"药石科技(300725.SZ)参股公司药捷安康在香港联交所主板挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2545419002","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545419002?lang=zh_cn&edition=full","pubTime":"2025-06-23 20:01","pubTimestamp":1750680101,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药石科技(300725.SZ)发布公告,公司参股公司药捷安康(南京)科技股份有限公司(简称“药捷安康”)于2025年6月23日在香港联合交易所有限公司(简称“香港联交所”)主板挂牌上市,股份代号02617,药捷安康本次公开发行新股15,281,000股,发行价格为13.15港元/股。药捷安康本次全球发售完成后,公司(含全资子公司)合计持有其股份数为2292.87万股,占其发行后总股份数约5.78%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"03e355b77ba35e6757abcf8175791b1c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"药石科技(300725.SZ)参股公司药捷安康在香港联交所主板挂牌上市","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300725","BK0229"],"gpt_icon":0},{"id":"2544163603","title":"药石科技收盘下跌2.62%,滚动市盈率32.83倍,总市值67.59亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544163603","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544163603?lang=zh_cn&edition=full","pubTime":"2025-06-19 18:08","pubTimestamp":1750327681,"startTime":"0","endTime":"0","summary":"6月19日,药石科技今日收盘33.84元,下跌2.62%,滚动市盈率PE达到32.83倍,总市值67.59亿元。从行业市盈率排名来看,公司所处的化学制药行业市盈率平均52.37倍,行业中值30.11倍,药石科技排名第93位。资金流向方面,6月19日,药石科技主力资金净流出2268.57万元,近5日总体呈流出状态,5日共流出10908.77万元。最新一期业绩显示,2025年一季报,公司实现营业收入4.55亿元,同比20.55%;净利润3579.08万元,同比-27.67%,销售毛利率30.34%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/19180851174301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0229","300725"],"gpt_icon":0},{"id":"2543506243","title":"药石科技:截至2025年6月10日,公司股东人数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2543506243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543506243?lang=zh_cn&edition=full","pubTime":"2025-06-13 16:36","pubTimestamp":1749803782,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技(300725)06月13日在投资者关系平台上答复投资者关心的问题。投资者提问:请问最新一期公司的股东人数是多少?药石科技回复:截至2025年6月10日,公司股东人数为:36,666名。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061300024534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"gpt_icon":0},{"id":"2538232744","title":"药石科技:公司董事会将在授权期限内灵活安排融资事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=2538232744","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538232744?lang=zh_cn&edition=full","pubTime":"2025-05-28 16:51","pubTimestamp":1748422270,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技05月28日在投资者关系平台上答复投资者关心的问题。公司5月16日召开的年度股东大会已授权董事会以简易程序向特定对象发行融资总额不超过人民币3亿元且不超过最近一年末净资产20%的股票,授权期限为2024年年度股东大会审议通过之日起至2025年年度股东大会召开之日止。公司董事会将在授权期限内,根据公司发展节奏和融资需求,灵活安排是否进行融资及何时进行融资,截至目前暂未启动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052800025719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"gpt_icon":0},{"id":"2538106268","title":"药石科技:年产155吨创新药及关键中间体CDMO建设项目建设周期为2023年7月至2026年7月","url":"https://stock-news.laohu8.com/highlight/detail?id=2538106268","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538106268?lang=zh_cn&edition=full","pubTime":"2025-05-26 20:51","pubTimestamp":1748263885,"startTime":"0","endTime":"0","summary":"证券之星消息,药石科技05月26日在投资者关系平台上答复投资者关心的问题。药石科技回复:投资者您好,公司募投项目“年产155吨创新药及关键中间体CDMO建设项目” 建设周期为2023年7月至2026年7月。目前,项目配套的研究院改造工程已经启动建设,部分公辅设备已经到位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052600031387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229","159992","06978","BK1574","BK1161"],"gpt_icon":0},{"id":"2537168899","title":"每周股票复盘:药石科技(300725)股东吴希罕减持74.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2537168899","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537168899?lang=zh_cn&edition=full","pubTime":"2025-05-24 06:42","pubTimestamp":1748040141,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘,药石科技报收于33.54元,较上周的31.94元上涨5.01%。本周,药石科技5月23日盘中最高价报34.46元。药石科技当前最新总市值66.99亿元,在医疗服务板块市值排名20/50,在两市A股市值排名2250/5148。本周关注点股本股东变化:股东吴希罕于2025年5月13日至2025年5月20日间合计减持74.38万股股本股东变化股东吴希罕于2025年5月13日至2025年5月20日间合计减持74.38万股,占公司目前总股本的0.3724%,变动期间该股股价上涨1.33%,截止5月20日收盘报32.86元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400009595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"gpt_icon":0},{"id":"2537123219","title":"药石科技收盘下跌1.72%,滚动市盈率31.68倍,总市值65.21亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537123219","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537123219?lang=zh_cn&edition=full","pubTime":"2025-05-22 17:53","pubTimestamp":1747907634,"startTime":"0","endTime":"0","summary":"5月22日,药石科技今日收盘32.65元,下跌1.72%,滚动市盈率PE达到31.68倍,总市值65.21亿元。从行业市盈率排名来看,公司所处的化学制药行业市盈率平均49.06倍,行业中值29.78倍,药石科技排名第94位。股东方面,截至2025年4月18日,药石科技股东户数33548户,较上次减少193户,户均持股市值35.28万元,户均持股数量2.76万股。最新一期业绩显示,2025年一季报,公司实现营业收入4.55亿元,同比20.55%;净利润3579.08万元,同比-27.67%,销售毛利率30.34%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/22175350593450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300725","BK0229"],"gpt_icon":0},{"id":"2537933043","title":"5月21日药石科技发布公告,股东减持74.38万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2537933043","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537933043?lang=zh_cn&edition=full","pubTime":"2025-05-21 21:01","pubTimestamp":1747832462,"startTime":"0","endTime":"0","summary":"证券之星消息,5月21日药石科技发布公告《药石科技:关于公司股东减持股份实施情况的公告》,其股东吴希罕于2025年5月13日至2025年5月20日间合计减持74.38万股,占公司目前总股本的0.3724%,变动期间该股股价上涨1.33%,截止5月20日收盘报32.86元。股东增减持详情见下表:根据药石科技2025年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052100037686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"gpt_icon":0},{"id":"2537671432","title":"药石科技:公司提供的产品和服务主要视合作伙伴的项目需求而定","url":"https://stock-news.laohu8.com/highlight/detail?id=2537671432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537671432?lang=zh_cn&edition=full","pubTime":"2025-05-21 11:37","pubTimestamp":1747798627,"startTime":"0","endTime":"0","summary":"请问公司具备麦角硫因生物合成技术吗?公司提供的产品和服务主要视合作伙伴的项目需求而定,有关公司业务能力的介绍请参看公司《2024年年度报告》或公司官网,谢谢!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052100014459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300725"],"gpt_icon":0},{"id":"2537021671","title":"药石科技:为全球医药研发制造领域提供创新化学产品和服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2537021671","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537021671?lang=zh_cn&edition=full","pubTime":"2025-05-21 11:35","pubTimestamp":1747798502,"startTime":"0","endTime":"0","summary":"金融界5月21日消息,有投资者在互动平台向药石科技提问:麦角硫因在食品、保健品、化妆品领域应用广泛,主要原因是其独特的抗氧化、抗衰老特性,抑制减轻炎症,改善心血管功能。请问公司具备麦角硫因生物合成技术吗?公司回答表示:投资者您好,我公司是全球医药研发和制造领域创新化学产品和服务供应商。公司致力于通过研发和生产过程中的化学和低碳技术的创新,帮助合作伙伴提高新药发现及开发效率,确保产品质量的稳定,持续降低研发和生产成本。公司提供的产品和服务主要视合作伙伴的项目需求而定,有关公司业务能力的介绍请参看公司《2024年年度报告》或公司官网,谢谢!\n\n\r\n 责任编辑:栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/21113550556191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300725","BK1515","09939","BK0229","BK1574","159938","BK1161"],"gpt_icon":0},{"id":"2534177295","title":"药石科技(300725)4月18日股东户数3.35万户,较上期减少0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534177295","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534177295?lang=zh_cn&edition=full","pubTime":"2025-05-09 17:54","pubTimestamp":1746784494,"startTime":"0","endTime":"0","summary":"证券之星消息,近日药石科技披露,截至2025年4月18日公司股东户数为3.35万户,较3月31日减少193.0户,减幅为0.57%。在医疗服务行业个股中,药石科技股东户数低于行业平均水平,截至4月18日,医疗服务行业平均股东户数为4.39万户。从股价来看,2025年3月31日至2025年4月18日,药石科技区间跌幅为14.94%,在此期间股东户数减少193.0户,减幅为0.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900028677.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300725","BK0229"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753320197714,"stockEarnings":[{"period":"1week","weight":0.0271},{"period":"1month","weight":0.2065},{"period":"3month","weight":0.3222},{"period":"6month","weight":0.3239},{"period":"1year","weight":0.4779},{"period":"ytd","weight":0.2395}],"compareEarnings":[{"period":"1week","weight":0.0224},{"period":"1month","weight":0.0594},{"period":"3month","weight":0.0864},{"period":"6month","weight":0.1014},{"period":"1year","weight":0.2288},{"period":"ytd","weight":0.0688}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京药石科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"36666人(较上一季度增加9.29%)","perCapita":"4599股","listingDate":"2017-11-10","address":"江苏省南京市浦口区江北新区华盛路81号","registeredCapital":"19973万元","survey":" 南京药石科技股份有限公司的主营业务是药物分子砌块的研发、工艺开发、生产和销售;基于药物分子砌块的药物发现解决方案;基于药物分子砌块的药物开发和生产服务(CDMO)。公司的主要产品是药物研究阶段的产品和服务、化学研发服务、药物开发及商业化阶段的产品和服务。公司凭借连续流创新工艺(连续脱羧、脱色、萃取和分离)、微填充床技术应用(连续空气氧化和加氢还原胺化)两项突破性技术,在与全球知名CDMO公司的激烈角逐中,连续两年(2023 年、2024 年)荣获美国化学学会(ACS)CMO 绿色化学卓越奖。","listedPrice":11.32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药石科技(300725)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药石科技(300725)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药石科技,300725,药石科技股票,药石科技股票老虎,药石科技股票老虎国际,药石科技行情,药石科技股票行情,药石科技股价,药石科技股市,药石科技股票价格,药石科技股票交易,药石科技股票购买,药石科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药石科技(300725)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药石科技(300725)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}